Karam, Marc C., Al-Kouba, Jane E., Bazzi, Samer I., Smith, Catherine B. and Leung, Lawrence (2011) Interleukin-13 reduces hyperalgesia and the level of interleukin-1[beta] in BALB/c mice infected with 'Leishmania major' with an up-regulation of interleukin-6. Journal of Neuroimmunology, 234(1-2), pp. 49-54. ISSN (print) 0165-5728

Abstract

The anti-inflammatory cytokines interleukin-10 (IL-10) and interleukin-13 (IL-13) were shown to reduce hyperalgesia in some models such as rats exposed to UV rays. In addition, IL-10 was also shown to reduce hyperalgesia in high dose of 'Leishmania major'-induced inflammation in BALB/c mice accompanied by a significant decrease in the levels of interleukin-1β (IL-1β) in the paws of infected mice, while no effect on the levels of IL-6 was observed. In this study, we injected BALB/c mice with a high dose of 'L. major' and treated them with IL-13 (15 ng/animal) for twelve days (excluding the weekends) and hyperalgesia was assessed using thermal pain tests. Furthermore, the levels of IL-1β and IL-6 were also assessed at different post-infection days. Our results show that IL-6 and more importantly IL-1β don't play a direct role in the 'L. major'-induced hyperalgesia and that IL-13 induces this hyperalgesia through the down-regulation of IL-1β and another proinflammatory cytokine (most probably TNF-α). Furthermore, our data show that IL-13 leads to the upregulation of the level IL-6 which initially seems to have no direct role in the induced hyperalgesia. Therefore, we suggest that the 'L. major'-induced hyperalgesia is mainly mediated by the cytokine cascade leading to the production of sympathetic amines.

Actions (Repository Editors)

Item Control Page